Skip to main content

Adult and Pediatric Hemoconcentrators Market Demands and Gross Margin 2028

 


A hemoconcentrator is a device used for removal of fluid during cardio bypass surgery. Hemoconcentrators are introduced in extracorpeal circuit where it controls hemodilution, maintains hematocrit levels, and reduces the need for additional blood products during and after surgery. Hemoconcentrators are widely used during cardiac bypass surgery and has become the ideal method for controlling hemodilution during cardiopulmonary surgery by surgeons and perfusionists.

High prevalence of cardiovascular diseases is expected to lead to high demand for hemoconcentrators and thus drive the adult and pediatric hemoconcentrators market growth

Hemoconcentrators are widely used devices during cardio bypass surgery. High prevalence of cardiovascular diseases is expected to be a major factor propelling demand for hemoconcentrator. According to the data published by World Health Organization (WHO) in 2017, cardiovascular diseases is the leading cause of death globally. Annually, more people die from cardiovascular diseases than from any other cause.

According to the data published by World Health Organization (WHO) in 2018, an estimated around 17.7 million people died from cardiovascular diseases in 2015, representing 31% of all global deaths. Such high prevalence of cardiovascular diseases is expected to lead to high demand for hemoconcentrators and drive global adult and pediatric hemoconcentrators market growth over the forecast period.

Key players in the market include Terumo Corporation, LivaNova Plc., Medtronic Plc., etc. All these key players manufacture and market their own novel hemoconcentrators developed from different materials with different advantages. For instance, in 2011 Minntech Corporation (a Cantel Medical Corporation company) introduced The Hemocor HPH Hemoconcentrator made with Eastman Chemical Company’s Tritan Copolyester. Tritan is a new-generation copolyester that offers the benefits of toughness, chemical resistance, and color stability after sterilization for renal medical device housings.

The global adult and pediatric hemoconcentrators market size was valued at US$ 10.7 Mn in 2017, and is expected to witness a CAGR of 3.3% during the forecast period (2018 – 2026).

North America is expected to hold dominant position in the market, owing to frequent approvals of new adult and pediatric hemoconcentrators by regulatory bodies

North America is expected to hold dominant position in global adult and pediatric hemoconcentrators market over the forecast period, owing to high prevalence of cardiovascular diseases in the U.S. and rising healthcare awareness in region.

 

Comments

Popular posts from this blog

The Global Autoclave Equipment Market Continues To Grow Owing To the Rising Demand from Healthcare Sectors for Sterilizing Medical Equipment to Ensure the Safety of the Post-Surgical Period

  Autoclave equipment is the most popular sterilization method in the industry and is used for many applications including the manufacture of food products. It is widely used in the foodservice industry to sterilize and cleanse equipment used in the process of preparing and serving food. The autoclave is the abbreviated form of autolysis which means oxidation. Autoclaves have various parts including an electric motor, a condenser, and a burner. Autoclave equipment includes vials for sealing the autoclave, a glass or plastic container that has been lined with wax or plastic, and the appropriate autoclave equipment accessories such thermometer for measuring the temperature of the autoclave. All modern steam sterilizing equipment & autoclave machines provide a much-refined workflow experience, which makes you reconsider whether or not steam sterilizing is all it can be. A wide range of sterilization methods is used for sterilizing your medical and laboratory specimen so the right ...

Biologics Market Increasing Prevalence of Chronic Diseases to Augment Growth of the market

  A  biologic  drug ( biologics ) is a product that is produced from living organisms or contains components of living organisms.  Biologic  drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Market Dynamics In the recent past, several novel biopharmaceutical products were approved by major regulatory bodies and major players in the market have launched various novel and innovative biopharmaceutical products. Rapid approvals and launches of novel products in the market are expected to be major drivers for growth of the biologicsmarket . 

Treprostinil Drugs Market - High Prevalence of Pulmonary Arterial Hypertension and R&D of New Formulations of Treprostinil to Augment Growth of market

  Treprostinil is an antihypertensive agent used to treat patients with pulmonary arterial hypertension. It can also be used in the treatment of Degos disease, an extremely rare disorder in which small and medium sized arteries become blocked (occlusive arteriopathy), restricting the flow of blood to affected areas. Market Dynamics High prevalence of pulmonary arterial hypertension is expected to propel growth of the treprostinil drugs market . For instance, according to the study, ‘High Geographic Prevalence of Pulmonary Artery Hypertension: Associations with Ethnicity, Drug Use, and Altitude’, published in February 2020, in the journal Pulmonary Circulation, the overall pulmonary arterial hypertension incidence was 14 cases per million and the annual period prevalence of pulmonary arterial hypertension was 93 cases per million. Decline in new prescriptions for treprostinil-based products is expected to hinder growth of the treprostinil drugs market. For instance, United The...